NEW YORK, Feb 14 – Incyte has licensed its databases and will provide custom genomic services to GenomicFX, a company that is developing genomic diagnostic tools for cattle and swine breeding and production, the companies said Wednesday.

GenomixFX of Austin, Texas, has licensed Incyte's LifeSeq Gold and Zooseq databases for an undisclosed amount. In addition, Incyte will provide GenomicFX with custom services that will enable it to create proprietary cattle and swine genome databases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.